Induction treatment response
| Response . | All patients . | DEL . | DHL . |
|---|---|---|---|
| ORR | 90.9% (50/55) | 93.8% (30/32) | 87% (20/23) |
| CR | 83.6% (46/55) | 84.4% (27/32) | 82.6% (19/23) |
| PR | 7.3% (4/55) | 9.4% (3/32) | 4.3% (1/23) |
| PD | 9.1% (5/55) | 6.3% (2/32) | 13% (3/23) |
| Response . | All patients . | DEL . | DHL . |
|---|---|---|---|
| ORR | 90.9% (50/55) | 93.8% (30/32) | 87% (20/23) |
| CR | 83.6% (46/55) | 84.4% (27/32) | 82.6% (19/23) |
| PR | 7.3% (4/55) | 9.4% (3/32) | 4.3% (1/23) |
| PD | 9.1% (5/55) | 6.3% (2/32) | 13% (3/23) |
PD, progressive disease.